GeneSolve supports projects providing solutions challenges from users across industry sectors. This user driven program is unique in that it encourages a collaborative research approach between industry users and academia.Status: Open Learn More
Genome BC invests in research that aligns with the needs of areas of strategic importance to British Columbia such as health, forestry, fisheries and aquaculture, agrifood, energy, mining and environment.
By working collaboratively with government, academia and industry, Genome BC’s goal is to translate the excellent research carried out in universities into applications that will ultimately generate social and economic benefits for BC and Canada.
Genome BC’s co-funding approach to research investment follows neither a government-only “granting council” model, nor an industry-only “portfolio management” approach. It is a unique approach that relies on collaborative research agreements and commitments to milestones and outputs, a model perhaps best described as “contract” research. It is important to note that discovery science is an engine that drives future developments in genomics and Genome BC funds research across the research continuum from discovery through application through translation.
The goal of the Sector Innovation Program is to support projects that will address the needs of each key sector and have the potential to generate social, environmental and economic benefits for British Columbia in the future.Status: Open Learn More
The Genomic Applications Partnership Program (GAPP) represents a key element in Genome Canada’s strategic plan towards funding downstream research and development (R&D) projects that are driven by challenges and opportunities facing users of genomics based technologies.Status: Open Learn More
This program aims to strengthen the connections between researchers, users and other stakeholders on issues that could impact the uptake and application of genomic technologies, including commercialization. The goal of the team program is to support and enhance GE3LS research that addresses important and overarching challenges that affect the adoption and uptake of the outcomes from genomics research and/or accelerate the synthesis and dissemination of research pertinent to users, including policy-makers within a sector.Status: Open Learn More
Genome Canada has launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step. to initiate this ambitious program, Genome Canada is encouraging the submission of projects to the Genomic Applications Partnership Program (GAPP) that will translate research into clinical implementation with the goal of having genome sequencing offered as a clinical genetic test within an established diagnostic and clinical care pathway for rare diseases.Status: Open Learn More
Does your company have a clear pathway to commercialization for an innovative life science technology? Learn more about Genome BC's I² program that provides early stage commercialization support for companies developing BC-based technologies.Status: Open Learn More